Patient-Centered Approach in IBS-C Management.
作者信息
Kongara Kavita
机构信息
Motility Clinical Chair, United Digestive Georgia Physician Executive Committee Member, United Digestive Physician, Atlanta Gastroenterology Associates Atlanta, Georgia.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.
Abstract
摘要
相似文献
1
Patient-Centered Approach in IBS-C Management.
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):362-373.
3
A Multicenter Randomized Controlled Trial of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet vs Low-Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.
Am J Gastroenterol. 2024 Sep 1;119(9):1901-1912. doi: 10.14309/ajg.0000000000002862. Epub 2024 May 8.
4
Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome.
Aliment Pharmacol Ther. 2015 Jun;41(12):1256-70. doi: 10.1111/apt.13167. Epub 2015 Apr 22.
5
Evaluation of the combined use of linaclotide and probiotics on clinical treatment efficacy and quality of life in patients with constipation-predominant irritable bowel syndrome.
Am J Transl Res. 2025 May 15;17(5):3333-3344. doi: 10.62347/GNSB4367. eCollection 2025.
6
Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.
Sci Rep. 2025 Jul 1;15(1):21550. doi: 10.1038/s41598-025-08599-7.
7
A Patient-Centered Approach to Managing IBS-C and CIC.
J Fam Pract. 2023 Jul;72(6 Suppl):S1-S6. doi: 10.12788/jfp.0514.
8
Exploring Dietitians' Perspectives Toward Current Practices and Services in Relation to Irritable Bowel Syndrome Management in Clinical Settings Across the United Kingdom: A Qualitative Study.
J Acad Nutr Diet. 2025 Mar;125(3):335-347. doi: 10.1016/j.jand.2024.07.169. Epub 2024 Jul 30.
9
Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
Nutr Rev. 2025 Jan 25. doi: 10.1093/nutrit/nuae217.
10
Diagnosis and management of IBS.
Nat Rev Gastroenterol Hepatol. 2010 Oct;7(10):565-81. doi: 10.1038/nrgastro.2010.137.
本文引用的文献
1
Plecanatide Is Efficacious in Patients With Irritable Bowel Syndrome With Constipation and Bloating: Evaluation Using Trisymptom Composite Endpoints.
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):12-13.
2
Irritable Bowel Syndrome With Constipation Poses a Substantial Burden to Patient Overall Health Status and Quality of Life: Results From the IBS in America 2024 Real-World Survey.
Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 9):2-3.
3
Managing IBS-C: Focus on Symptom Control.
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):216-226.
4
Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
Dig Dis Sci. 2024 May;69(5):1731-1738. doi: 10.1007/s10620-024-08330-y. Epub 2024 Apr 9.
5
Mechanism of Action Considerations in the Management of IBS-C.
Gastroenterol Hepatol (N Y). 2023 Dec;19(12):749-756.
6
Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
Am J Gastroenterol. 2024 May 1;119(5):937-945. doi: 10.14309/ajg.0000000000002685. Epub 2024 Jan 31.
7
Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome With Diarrhea From Other Organic Gastrointestinal Diseases, With Special Focus on Exocrine Pancreatic Insufficiency.
J Clin Gastroenterol. 2023 Aug 1;57(7):663-670. doi: 10.1097/MCG.0000000000001855.
8
Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
Nutrients. 2023 Mar 28;15(7):1647. doi: 10.3390/nu15071647.
9
Approach to Disorders of Gut-Brain Interaction.
Mayo Clin Proc. 2023 Mar;98(3):458-467. doi: 10.1016/j.mayocp.2022.11.001.
10
The neurobiology of irritable bowel syndrome.
Mol Psychiatry. 2023 Apr;28(4):1451-1465. doi: 10.1038/s41380-023-01972-w. Epub 2023 Feb 2.
Zotero 插件